Gianello (PubMed) Research Focus : Mechanistic Preclinical Research Title : Development of a Human Growth Hormone Peptide Analogue AOD9604 into an Anti-Obesity Drug (Book chapter, Peptides: The Wave of the Future, APSY vol 7, 2001) Authors : Woei-Jia Jiang, Robert Gianello, Mark Heffernan, Esra Ogru, Roksan Libinaki, Frank Ng (SpringerLink) Research Focus : Preclinical Lipid Metabolism Studies (Mice) Title : The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and -AR knockout mice (Endocrinology, Dec 2001) Authors : M
Obes Rev
B12 Deficiency Correction: Weekly For confirmed B12 deficiency or pernicious anemia: weekly injections for 48 weeks to saturate body stores, then monthly maintenance
Generally, this improves results
Discuss your medical history, goals, and any existing conditions that could influence safe peptide use
Possible Side Effects Cagrilintide is generally well-tolerated in clinical research studies, with most reported effects being mild and transient